JFG
LAB icon

Jefferies Financial Group’s Standard BioTools LAB Stock Holding History

Jefferies Financial Group’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.5K Buy
+17,675
New +$16.7K ﹤0.01% 1610
2024
Q2 		– Sell
-119,400
Closed -$324K – 1654
2024
Q1 		$324K Buy
119,400
+63,000
+112% +$152K ﹤0.01% 1188
2023
Q4 		$125K Hold
56,400
– – ﹤0.01% 1522
2023
Q3 		$164K Buy
+56,400
New +$148K ﹤0.01% 1380

Other funds holding LAB

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Jefferies Financial Group's LAB Position: Q2 2026 in Review

Jefferies Financial Group opened a new position in Standard BioTools (LAB) in Q2 2026: 17,675 shares worth $14.5K. The stake represents ﹤0.01% of the portfolio and ranks #1610 among its holdings. This is a return to the name: Jefferies Financial Group previously reported a position in LAB as recently as Q1 2024.

Jefferies Financial Group first reported a position in LAB in Q3 2023 and has held it in 4 quarters since. The position peaked at $324K in Q1 2024. 144 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

  • Jefferies Financial Group held 17,675 shares of Standard BioTools worth $14.5K as of Q2 2026.
  • Standard BioTools was a new Jefferies Financial Group position in Q2 2026.
  • Standard BioTools made up ﹤0.01% of Jefferies Financial Group's portfolio in Q2 2026, its #1610 holding.
  • Jefferies Financial Group first reported a position in Standard BioTools in Q3 2023 and has held it in 4 quarters since.
  • Jefferies Financial Group's Standard BioTools position peaked at $324K in Q1 2024.
  • 144 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.